Authors:
Owens, RC
Tessier, P
Nightingale, CH
Ambrose, PG
Quintiliani, R
Nicolau, DP
Citation: Rc. Owens et al., Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens, INT J ANT A, 17(6), 2001, pp. 483-489
Citation: Rc. Owens, Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes, PHARMACOTHE, 21(3), 2001, pp. 301-319
Citation: Rc. Owens, Choosing the ideal antibiotic therapy and the role of the newer fluoroquinolones in respiratory tract infections, AM J M CARE, 6(8), 2000, pp. S442-S447
Citation: Pg. Ambrose et Rc. Owens, New antibiotics in pulmonary and critical care medicine: Focus on advancedgeneration quinolones and cephalosporins, SEM RESP CR, 21(1), 2000, pp. 19-32
Citation: J. Mcnabb et al., Comparison of azithromycin leukocyte disposition in healthy volunteers andvolunteers with AIDS, INT J ANT A, 16(1), 2000, pp. 37-43
Authors:
Onyeji, CO
Bui, KQ
Owens, RC
Nicolau, DP
Quintiliani, R
Nightingale, CH
Citation: Co. Onyeji et al., Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia, INT J ANT A, 12(2), 1999, pp. 107-114
Citation: Acf. Keung et al., Pharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: a phase I study, ANTIM AG CH, 43(5), 1999, pp. 1230-1233
Citation: Mk. Lacy et al., Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and cefuroxime axetil against Streptococcus pneumoniae, INT J ANT A, 10(4), 1998, pp. 279-283